Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era
出版年份 2018 全文链接
标题
Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era
作者
关键词
-
出版物
BRITISH JOURNAL OF SURGERY
Volume 105, Issue 8, Pages 1020-1027
出版商
Wiley
发表日期
2018-04-18
DOI
10.1002/bjs.10809
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study
- (2018) Arie J. Verschoor et al. VIRCHOWS ARCHIV
- Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
- (2017) Paolo G. Casali et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial
- (2016) Peter Reichardt et al. BMC CANCER
- Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies
- (2016) Kjetil Søreide et al. Cancer Epidemiology
- The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors
- (2016) Emily Z. Keung et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study
- (2016) M.F.J. Seesing et al. EJSO
- Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group
- (2016) Anna Patrikidou et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial
- (2016) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Subtypes ofKIT/PDGFRAWild-Type Gastrointestinal Stromal Tumors
- (2016) Sosipatros A. Boikos et al. JAMA Oncology
- Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST)
- (2015) Klaus Kramer et al. BMC CANCER
- The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours
- (2015) Carlos H. Barrios et al. EUROPEAN JOURNAL OF CANCER
- GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer
- (2015) Angela Cioffi et al. JOURNAL OF CLINICAL ONCOLOGY
- Underreporting of Gastrointestinal Stromal Tumors: Is the True Incidence Being Captured?
- (2015) Audrey H. Choi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Long-Term Surgical Outcome of 1057 Gastric GISTs According to 7th UICC/AJCC TNM System
- (2015) Min-Chan Kim et al. MEDICINE
- Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update
- (2015) Brian P. Rubin et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998–2008: a nation-wide cancer registry-based study
- (2014) Nai-Jung Chiang et al. BMC CANCER
- Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib
- (2014) Heikki Joensuu et al. CANCER
- Epidemiology of Gastrointestinal Stromal Tumors in the Era of Histology Codes: Results of a Population-Based Study
- (2014) G. L. Ma et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
- (2013) Piotr Rutkowski et al. ANNALS OF SURGICAL ONCOLOGY
- Incidence of Soft Tissue Sarcoma Focusing on Gastrointestinal Stromal Sarcoma in Osaka, Japan, During 1978–2007
- (2013) Etsuko Nomura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure
- (2012) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- Outcome of Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors in the Tyrosine Kinase Inhibitor Era
- (2012) P. A. Cassier et al. CLINICAL CANCER RESEARCH
- Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib
- (2012) R. Tielen et al. EJSO
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
- (2012) Ronald Tielen et al. World Journal of Surgical Oncology
- A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors
- (2009) Inigo Espinosa et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors
- (2009) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Surgical Therapy for Gastrointestinal Stromal Tumours of the Upper Gastrointestinal Tract
- (2009) Amitabha Das et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
- (2009) Jason S Gold et al. LANCET ONCOLOGY
- Risk stratification of patients diagnosed with gastrointestinal stromal tumor
- (2008) Heikki Joensuu HUMAN PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started